Metraipolis › archive › dc_0631e162bfc9
SLC16A3 drives lung adenocarcinoma progression and gefitinib resistance through coordinated regulation of ferroptosis and lactate metabolism — Europe PMC PMID:41293164
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41293164
- DOI
- 10.3389/fimmu.2025.1699540
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T17:03:58.905Z
- SHA-256 of the archived text
47da9e7cb00324ac3656c295443eb4fa6b1838e79d6782991210fe1e2e5adc35- Stable URL of this page
https://metraipolis.com/documento/dc_0631e162bfc9
How to cite
SLC16A3 drives lung adenocarcinoma progression and gefitinib resistance through coordinated regulation of ferroptosis and lactate metabolism — Europe PMC PMID:41293164 — Europe PMC (en), https://europepmc.org/article/MED/41293164 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0631e162bfc9 (Metraipolis archive dc_0631e162bfc9, sha256 47da9e7cb00324ac3656c295443eb4fa6b1838e79d6782991210fe1e2e5adc35)
BibTeX
@misc{dc0631e162bfc9,
title = {SLC16A3 drives lung adenocarcinoma progression and gefitinib resistance through coordinated regulation of ferroptosis and lactate metabolism — Europe PMC PMID:41293164},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41293164},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0631e162bfc9; sha256 47da9e7cb00324ac3656c295443eb4fa6b1838e79d6782991210fe1e2e5adc35},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41293164. Agents can read the archived copy with the MCP tool read_document.